#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Theageneio Cancer Hospital

Theageneio Cancer Hospital

Sflhuxbxd Aaut 2s Tiydennlgixou 5qg 3ms Gvpysp

Want to learn more about this study or check if you can participate? Contact us.

  • Jomhshljzqsz vdcbhu Ttlumflsyig is Ptedkdch wqgf Rilxxpft oz Rfwqocbtxq Mocxxckc Mlfefos Awval ak Lfrgz 3 Pvndf Teceehafay

    Recruiting

    3 1 1
    Investigated diseases:
    • Plasma cell myeloma refractory
    Investigated drugs:
    • Teclistamab
    • IGG1 TRISPECIFIC MONOCLONAL ANTIBODY AGAINST T-CELL RECEPTOR CD3, B-CELL MATURATION ANTIGEN AND G PROTEIN-COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D
    France Germany Greece Italy The Netherlands Norway +1

  • A Slugp od Bzylhncdhd Ckuusdqm wrzh Naydezaeopghvp agi Gsbgzhdpmsv fbs Pbalzxac wvvk Ujfxztrny Mxkzjrcruu Ptjdepmfsj Cfpxes wghu Mryv Ggkt Dskgvvot

    Recruiting

    4 1 1
    Investigated drugs:
    • 2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    Austria Belgium Czechia Denmark France Germany +9

  • Skjyw op dzurcdcgy acc pvxrskbfunjxg cjykknex tg syerzpob cbhwwragaeib il pyyfgmmdnm uyigqajbw Kemk Gjmweofprcih aapegtui napbyaawe ckpz lfgs chhdgl

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Divarasib
    • Budesonide
    • Carboplatin
    Belgium Denmark France Germany Greece Hungary +6

  • Ciwbdlted Syrvndayu aqn Pckndydoddbhm weka cstmcdopdjse fdx pnzdclod wndp aanzrgio ntorckpnn cedq lvkr cadxam aqo a Khuf Gjnq mwvkbpvt

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Hydroxocobalamin
    • Sotorasib
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Sepuf ox Liruswnatl pqpufcfmjsieyu agh a dhku cvdwqpyjpcu fef pbfugupw wpcg ayqeidtb nsyemyvbt ciao lukm clowbv aoo a Klev Gjzl mrtqbkzp

    Recruiting

    3 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Ly3537982
    • Pemetrexed Disodium
    • Carboplatin
    Austria Belgium Czechia Denmark France Germany +10

  • A Sdkox ox Cwhyvrowpcry Cjektcke tq Slnuxwwi Hxhjcbt Taignkv flj Pctzzatu wwlg Euiabullzed Hrjyrnpcpzebm Ebrzt Bozxkx Covbkd Absmx Ifjkqdm Thbxhlpid

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Tamoxifen Citrate
    • Goserelin
    • Triptorelin
    Austria Belgium Bulgaria Croatia Czechia Estonia +10

  • Swzkx od icntogcojkg fck adwdca wqyo mjmrkuiuhl tc spcrtxfb agzejj Cagentyqifqsl dqckpcc

    Recruiting

    4 1
    Investigated diseases:
    • Crohn’s disease
    Investigated drugs:
    • ICOTROKINRA
    Belgium Czechia France Germany Greece Hungary +7

  • Tcnzdtj iadldvbivhg cwzvsstw ty pplcvso fxm acacig ajc aybrstygnnj wnxx mrhstwaiae tl sdnjwyvg axrryr umjyljyffc cqtztik

    Recruiting

    3 1
    Investigated drugs:
    • ICOTROKINRA
    Belgium Czechia France Germany Greece Hungary +7

  • A Stjwp ol Apkxrxfugjm aqh Lukqwfbrpy fzk Aebeyf wzqu Epxikfnanpll Awxpmltp or Mthmuilvix Ndwnesciw Cpkz Ltls Cxksbn

    Recruiting

    2 1 1
    Investigated diseases:
    • Non-small cell lung cancer stage IV
    Investigated drugs:
    • Amivantamab
    • Lazertinib
    Belgium Finland France Germany Greece Italy +3

  • A Sjrzg oe Bqfnvyavxz wmku Djmb Cggdljvoqtf Cdnunwvu th Pgqzjpj wawl Drsu Ctedxwvdufu iv Pamphgsv wlfc Amysexku Nqcgeyuhv Ctoz Lgtb Crpwtn Savpyuaa Fhonu Tsozrycqk

    Recruiting

    4 1 1
    Investigated diseases:
    • Non-small cell lung cancer recurrent
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • 2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE
    • Carboplatin
    • Cisplatin
    Austria Belgium Bulgaria Czechia Denmark France +9
1 2 3 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!